In addition, Zhang et al. demonstrated that human adipose MSCs ameliorate liver fibrosis by restraining the PI3K/AKT/mTOR signaling pathway to suppress HSC activation and increase the metabolic rate of choline-phosphatidylcholine in a dose-dependent manner [121]. The gene discussed is AKT1; the disease is Hepatic fibrosis.